Fairfield Financial Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Fairfield Financial Advisors's NVO Position: Q1 2026 in Review
Fairfield Financial Advisors sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 6,066 shares — an estimated $309K sold.
Fairfield Financial Advisors first reported a position in NVO in Q1 2022 and held it in 15 quarters. The position peaked at $6.92M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Fairfield Financial Advisors reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Fairfield Financial Advisors sold 6,066 Novo Nordisk shares in Q1 2026, an estimated $309K.
- Fairfield Financial Advisors first reported a position in Novo Nordisk in Q1 2022 and held it in 15 quarters.
- Fairfield Financial Advisors's Novo Nordisk position peaked at $6.92M in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Fairfield Financial Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.